Renee Tringali
Psychiatric/Mental Health · Chesterfield, MINPI 1245751916
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 248 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,337, more than ten times the $17 reported in 2022. Among psychiatric/mental health clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 248 payments — averaging $21.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Alkermes, Inc.$880
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$784
- Otsuka America Pharmaceutical, Inc.$555
- Teva Pharmaceuticals USA, Inc.$475
- Johnson & Johnson$268
- plus $1K from 13 others
What the payments were for
- Food & beverage$5,24798%
- Education$1192%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$944
- VRAYLAR$486
- ARISTADA$456
- CAPLYTA$249
- INGREZZA$125
- ABILIFY MAINTENA$125
- ABILIFY ASIMTUFII$125
- INVEGA SUSTENNA$125
- COBENFY$122
- Austedo XR$119
- ARISTADA INITIO$114
How this compares
$5,366 in reported general payments places this provider in the 90th percentile of 638 psychiatric/mental health providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 18 | $565 |
| Bupropion XlBupropion Hcl | 13 | $318 |
| Quetiapine Fumarate | 24 | $164 |
| Escitalopram Oxalate | 11 | $142 |
| Buspirone Hcl | 12 | $90 |
| Lorazepam | 11 | $87 |
| Lamotrigine | 13 | $67 |
| Trazodone Hcl | 12 | $24 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Chesterfield
- Duren GutierrezSouthfield$207K
- Tamlynn EvansTraverse City$78K
- Shiba NixonClarkston$60K
- Amy AmesClinton Township$43K
- Cody ShinavierClarkston$41K
- Oksana LidkeBattle Creek$30K
- Jennifer Wims-MaddenPontiac$28K
- Jessica ShantzWarren$21K
- Gladys KimeliSaginaw$17K
- Cynthia MaiSaginaw$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.